These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17002174)

  • 1. [COPD--chronic obstructive pulmonary disease and its implications for the human organism].
    Groneberg DA; Pleimes D; Golpon H; Welte T
    Versicherungsmedizin; 2006 Sep; 58(3):116-9. PubMed ID: 17002174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the COPD health care costs study. COPD in Germany--unrecognized and cost intensive].
    Krankenpfl J; 2003; 41(7-9):158-61. PubMed ID: 14705523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management and costs of chronic pulmonary obstructive disease in France in 2011].
    Laurendeau C; Chouaid C; Roche N; Terrioux P; Gourmelen J; Detournay B
    Rev Mal Respir; 2015 Sep; 32(7):682-91. PubMed ID: 25613440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
    Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
    Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.
    Souliotis K; Kousoulakou H; Hillas G; Tzanakis N; Toumbis M; Vassilakopoulos T
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1395-1400. PubMed ID: 28546747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma.
    Skrepnek GH; Skrepnek SV
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S129-38. PubMed ID: 15354678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.
    Wacker ME; Kitzing K; Jörres RA; Leidl R; Schulz H; Karrasch S; Karch A; Koch A; Vogelmeier CF; Holle R
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3437-3448. PubMed ID: 29270005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and global impact of chronic obstructive pulmonary disease.
    Mannino DM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic ischemic heart disease on the health care costs of COPD patients - An analysis of German claims data.
    Schwarzkopf L; Wacker M; Ertl J; Hapfelmeier J; Larisch K; Leidl R
    Respir Med; 2016 Sep; 118():112-118. PubMed ID: 27578479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global burden and impact of chronic obstructive pulmonary disease worldwide.
    Gulsvik A
    Monaldi Arch Chest Dis; 2001 Jun; 56(3):261-4. PubMed ID: 11665507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.
    Lisspers K; Johansson G; Jansson C; Larsson K; Stratelis G; Hedegaard M; Ställberg B
    Respir Med; 2014 Sep; 108(9):1345-54. PubMed ID: 25002194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of illness for asthma and COPD in adults in Germany].
    Kirsch F; Teuner CM; Menn P; Leidl R
    Gesundheitswesen; 2013 Jul; 75(7):413-23. PubMed ID: 23553190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics of COPD: literature review and experiences from field work.
    Nielsen R; Klemmetsby M; Gulsvik A
    Clin Respir J; 2008 Oct; 2 Suppl 1():104-10. PubMed ID: 20298358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
    Anees Ur Rehman ; Ahmad Hassali MA; Muhammad SA; Shah S; Abbas S; Hyder Ali IAB; Salman A
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):661-672. PubMed ID: 31596632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.